Role of Inflammatory Markers in Early Diagnosis of Neonatal Sepsis; C-Reactive Protein or Procalcitonin or Red Cell Distribution Width; A Hospital-Based Study

Authors

  • Prinka Bai Department of Pediatric Medicine, Ziauddin University Hospital, Karachi Pakistan
  • Heena Rais Department of Pediatric Medicine, Ziauddin University Hospital, Karachi Pakistan
  • Rabia Asif Department of Pediatric Medicine, Ziauddin University Hospital, Karachi Pakistan
  • Tayyaba Anwar Department of Pediatric Medicine, Ziauddin University Hospital, Karachi Pakistan
  • Sandhiya Kumari Department of Pediatric Medicine, Ziauddin University Hospital, Karachi Pakistan
  • Masab Azeem Department of Pediatric Medicine, Ziauddin University Hospital, Karachi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v73i6.9349

Keywords:

C-reactive protein, Neonatal sepsis, Procalcitonin, Red cell distribution width

Abstract

Objective: To find out the utilization of C-reactive protein (CRP), Procalcitonin (PCT) and red cell distribution width (RDW) in
diagnosing neonatal sepsis considering blood culture findings as gold standard.

Study Design: Cross-sectional validation study.

Place and Duration of Study: Neonatal Intensive Care Unit (NICU) of Dr Ziauddin Medical University, Karachi Pakistan,
from Feb to Jul 2022.

Methodology: A total of 42 neonates of either gender with the clinical diagnosis of neonatal sepsis were enrolled.
Demographical and clinical characteristics of all neonates were noted at the time of enrollment. A blood sample of 5 ml was
withdrawn for the evaluation of CRP, PCT and RDS. The association of different inflammatory markers with the outcome
(neonatal sepsis) was assessed.

Results: In 42 neonates, the mean age was 7.24±9.24 days, and 26 (61.9%) neonates were boys. Respiratory distress, reluctance to feed and hypoglycemia were the most frequent clinical presentations observed (19,45.2%), (14,33.3%) and (8,19.0%) neonates, respectively. Mean CRP levels among blood culture positive and negative neonates were 40.02±57.84mg/dl and 7.57±13.34 mg/dl, respectively, while the difference was statistically significant (p=0.0068). RDW (p=0.6488) and procalcitonin (0.9021) levels were not statistically significant differences among positive and negative neonates of blood culture.

Conclusion: The CRP was a significant predictor of neonatal sepsis, while RDW and procalcitonin did not have a significant
relationship with early prediction of neonatal sepsis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Mersha A, Worku T, Shibiru S, Bante A, Molla A, Seifu G, et al.,

Neonatal sepsis and associated factors among newborns in

hospitals of Wolaita Sodo Town, Southern Ethiopia. Res Reports

Neonatol 2019; 2019(9): 1-8.

https://doi.org/10.2147/RRN.S193074.

Fleischmann-Struzek C, Goldfarb DM, Schlattmann P,

Schlapbach LJ, Reinhart K, Kissoon N, et al. The global burden of

paediatric and neonatal sepsis: a systematic review. Lancet

Respir Med 2018; 6(3): 223-230.

https://doi.org/10.1016/s2213-2600(18)30063-8.

Yamey G, Horvath H, Schmidt L, Myers J, Brindis CD. Reducing

the global burden of Preterm Birth through knowledge transfer

and exchange: a research agenda for engaging effectively with

policymakers. Reprod Health 2016; 13(1): 26-28.

https://doi.org/10.1186/s12978-016-0146-8.

Rudd KE, Johnson SC, Agesa KM. Global, regional, and national

sepsis incidence and mortality, 1990-2017: analysis for the Global

Burden of Disease Study. Lancet 2020; 395(10219): 200-211.

https://doi.org/10.1016/s0140-6736(19)32989-7.

Ogundare E, Akintayo A, Aladekomo T, Adeyemi L, Ogunlesi T,

Oyelami O, et al. Presentation and outcomes of early and late

onset neonatal sepsis in a Nigerian Hospital. Afr Health Sci 2019;

(3): 2390-2399. https://doi.org/10.4314/ahs.v19i3.12

Giannoni E, Agyeman PKA, Stocker M, Klara MP, Heininger U,

Spycher BD, et al. Neonatal sepsis of early onset, and hospitalacquired and community-acquired late onset: A prospective

population-based cohort study. J Pediatr 2018; 201(1): 106-114.e4.

https://doi.org/10.1016/j.jpeds.2018.05.048.

Berardi A, Sforza F, Baroni L, Spada C, Ambretti S, Biasucci G, et

al. Epidemiology and complications of late-onset sepsis: an

Italian area-based study. PLoS One 2019; 14(11): e0225407.

https://doi.org/10.1371/journal.pone.0225407.

Gude SS, Peddi NC, Vuppalapati S, Venu Gopal S, Marasandra

Ramesh H, Gude SS, et al. Biomarkers of Neonatal Sepsis: From

Being Mere Numbers to Becoming Guiding Diagnostics. Cureus

; 14(3): e23215. https://doi.org/10.7759/cureus.23215.

Sampath S, Baby J, Krishna B, Dendukuri N, Thomas T. Blood

Cultures and Molecular Diagnostics in Intensive Care Units to

Diagnose Sepsis: A Bayesian Latent Class Model Analysis. Indian

J Crit Care Med 2021; 25(12): 1402-1407.

https://doi.org/10.5005%2Fjp-journals-10071-24051.

Ng S, Strunk T, Jiang P, Muk T, Sangild PT, Currie A. Precision

Medicine for Neonatal Sepsis. Front Mol Biosci 2018; 5:70

https://doi.org/10.3389%2Ffmolb.2018.00070.

Celik IH, Hanna M, Canpolat FE, Mohan P. Diagnosis of

neonatal sepsis: the past, present and future. Pediatr Res 2022;

(2): 337-350. https://doi.org/10.1038%2Fs41390-021-01696-z.

Jaswal RS, Kaushal RK, Goel A, Pathania K. Role of C-reactive

protein in deciding duration of antibiotic therapy in neonatal

septicemia. Indian Pediatr 2003; 40(9): 880-883.

Mally P, Xu J, Hendricks-Muñoz K. Biomarkers for neonatal

sepsis: recent developments. Res Reports Neonatol 2014; 4: 157-

http://doi.org/10.2147/RRN.S48316.

Jandial A, Kumar S, Bhalla A, Sharma N, Varma N, Varma S, et

al. Elevated Red Cell Distribution Width as a Prognostic Marker

in Severe Sepsis: A Prospective Observational Study. Indian J

Crit Care Med 2017; 21(9): 552-562.

https://doi.org/10.4103/ijccm.ijccm_208_17.

Sucilathangam G, Amuthavalli K, Velvizhi G, Ashihabegum MA,

Jeyamurugan T, Palaniappan N, et al. Early Diagnostic markers

for neonatal sepsis: comparing procalcitonin (PCT) and Creactive protein (CRP). J Clin Diagnostic Res 2012; 6(4): 627-631.

https://doi.org/10.7860/JCDR/2012/.2150.

Zhang K, Xie R, Li W. The application value of inflammatory

indicators and cytokine detection in the early diagnosis of

neonatal sepsis. Clin Blood Transfus Test 2019; 21(4): 435-436.

Yang T, Wang J. Comparison of pathogenic bacteria, cytokines

and immune function of sepsis between term and premature infants. Chinese J Emerg Resuscit Disaster Med 2020;

(2): 201–203.

Wu L, Li J, Ping L, Zhang X, Zhai L, Li Y, et al. Diagnostic Value

of Inflammatory Markers and Cytokines in Neonatal Sepsis. Evid

Based Complement Alternat Med 2022; 2022: 4143101.

https://doi.org/10.1155%2F2022%2F4143101.

Xu L, Li Q, Mo Z, You P. Diagnostic value of C-reactive protein

in neonatal sepsis: A meta-analysis. Europ J Inflamm 2016; 14(2):

-108. https://doi.org/10.1177/1721727X16646787.

Rashwan NI, Hassan MH, Mohey El-Deen ZM, Ahmed AE.

Validity of biomarkers in screening for neonatal sepsis - A single

center -hospital based study. Pediatr Neonatol 2019; 60(2): 149-

https://doi.org/10.1016/j.pedneo.2018.05.001

Downloads

Published

30-12-2023

How to Cite

Bai, P., Rais, H., Asif, R., Anwar, T., Kumari, S., & Azeem, M. (2023). Role of Inflammatory Markers in Early Diagnosis of Neonatal Sepsis; C-Reactive Protein or Procalcitonin or Red Cell Distribution Width; A Hospital-Based Study. Pakistan Armed Forces Medical Journal, 73(6), 1703–1706. https://doi.org/10.51253/pafmj.v73i6.9349

Issue

Section

Original Articles